The Cartiva SCI is a novel osteochondral defect repair implant with properties similar to those of cartilage, designed for the treatment of first metatarsophalangeal joint osteoarthritis.
Setting a new standard for treating hallux rididus
First new articular surface material approved by FDA in 18 years.1
The only FDA approved cartilage-like polymer.
Proven effective in the largest, longest multi-center trial ever conducted for first MTP OA.2
Study data evaluated as low risk of bias in comprehensive published review.3
Awarded the Roger A. Mann Award twice (2015 & 2017), for the best clinical research in foot and ankle.2,4